HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Intel

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
212
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Intel (INTC) Investors with Significant Losses and Persons Who May Assist Firm’s Investigation of Possible Securities Fraud to Contact Its Attorneys Now

SAN FRANCISCO, July 25, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges Intel Corporation (NASDAQ: INTC) investors who have suffered significant losses to submit their losses now .  Hagens Berman also encourages persons who may be able to assist the Firm’s investigation of possible securities fraud to contact the firm.

Relevant Holding Period: Before July 23, 2020 Visit: www.hbsslaw.com/investor-fraud/INTC Contact An Attorney Now: INTC@hbsslaw.com         844-916-0895

Intel Corporation (INTC) Investigation :

The investigation centers on whether Intel misrepresented and concealed manufacturing and performance issues with its next generation 7-nanometer chips.

Beginning at the Company’s 2019 annual investor conference, Intel continuously represented that it would start shipping its first 7nm chips in 2021.  The news was well-received since the Company claimed the 7nm chip would deliver double the area efficiency of its 10nm chips.  Moreover, in the wake of severe delays derailing its 10nm chips, Intel assuaged concerns by stating, “We’ve made time-to-market the priority,” and repeatedly affirmed the 7nm chip’s timetable.

But on July 23, 2020, Intel announced a significant delay in the rollout of its 7nm chip, thereby adversely impacting the Company’s roadmaps. On a call with analysts, Intel CEO Bob Swan said the Company had identified a “defect mode” in its 7nm process that caused yield degradation issues. As a result, Intel has invested in “contingency plans,” including outsourcing manufacturing to third-party foundries.  Consequently, the 7nm will likely not debut on the market until late 2022 or early 2023.   

Analysts were shocked by the Company’s disclosures, including Stacy Rasgon of Sanford C. Bernstein, reportedly calling the news of the 7nm delay “the worst we have seen in our career covering the company” and concluding, “Whatever little credibility they had is out of the window.”

On this news, Intel’s share price has sharply declined.

“We’re focused on investors’ losses and whether Intel misled investors about the 7nm schedule and related manufacturing issues,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you purchased shares of Intel and suffered significant losses, click here to discuss your legal rights with Hagens Berman .

Whistleblowers: Persons with non-public information regarding Intel should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 844-916-0895 or email INTC@hbsslaw.com .

About Hagens Berman Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.  The firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes is located at hbsslaw.com .  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .

Contact: Reed Kathrein, 510-725-3000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hot Chili Sizzles with La Verde Copper Drill Gains

Updated Category News Views 95

Big Copper Moves at La Verde: What's New? Look, when it comes to copper, Hot Chili Limited is throwing down some serious markers. You see, their La Verde project is turning into a hotbed of activity thanks to their latest drilling revelations. They've managed to confirm a second porphyry center, which is like finding another gold mine, except with copper. This essentially...

Continue Reading
Blue Moon Metals Scraps Major Acquisition Plan

Updated Category News Views 168

Blue Moon Metals' Acquisition Detour Blue Moon Metals Inc. (NASDAQ: BMM), a name that's been stirring up chatter for its ambitious mining ventures, has waved goodbye to its planned acquisition of 33 U.S.-based tungsten and antimony projects. This move, announced on October 30, 2026, may have caught some investors off guard. The acquisition sounded like a good fit: a...

Continue Reading
CMRE Facing Legal Heat Over Wage Allegations

Updated Category News Views 33

Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...

Continue Reading
Brewers '26 Win Fuels Cap Craze: New Era's Play

Updated Category News Views 52

Brewers: Finally on Top of the World Boy oh boy, the Milwaukee Brewers have finally done it! After years of being the underdogs, the team has clinched their first-ever World Series championship in 2026. You think you're dreaming, but no, it's the real deal. The Brewers, once just a hopeful name on the roster of Major League Baseball's teams, have stormed their way to a...

Continue Reading
Aemetis Faces Class Action Over Wage Violation Claims

Updated Category News Views 126

California's Alert: Labor Code Violations Under Scrutiny Allegations like these can shake things up pretty quick, especially when you're dealing with harsh financial climates. Aemetis Advanced Fuel Keyes, Inc. is in hot water yet again—this time, they're being called out for allegedly messing up the wage game for their workers. That's right, a class action lawsuit filed...

Continue Reading
UBCF Strikes Big in Times Square with New Billboards

Updated Category News Views 0

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 118

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 128

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 110

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading
PRTH Shareholder Concerns Amid Merger Investigation

Updated Category News Views 79

Behind Closed Doors: PRTH's Merger Drama Unfolds The market's got its share of tricky maneuvers and right now, Priority Technology Holdings, Inc. (NASDAQ:PRTH) is under the magnifying glass. Levi & Korsinsky, LLP has kicked off an investigation into the nitty-gritty of PRTH's acquisition by its largest shareholder—none other than their own Chairman and CEO, Thomas C....

Continue Reading

Top 5 Most Recently Viewed Articles

Fleet Team Appoints Marc Terwilliger as New VP for Warehousing

Updated Category News Views 214

Marc Terwilliger Joins Fleet Team as Vice President Fleet Team, a leader in fleet management and consulting, is excited to share the news of Marc Terwilliger's appointment as Vice President of Warehouse Systems. With nearly 20 years of experience in material handling and warehousing, Marc is set to make a significant impact on innovation and operational excellence within...

Continue Reading
Zenni Optical Unveils EyeQLenz™: Panel Discussion on Innovation

Updated Category News Views 342

Zenni Optical Launches EyeQLenz™ with Zenni ID Guard™ Zenni Optical recently introduced EyeQLenz™ with Zenni ID Guard™, an innovative lens designed to enhance eye protection and privacy. Following this exciting launch, Zenni hosted a panel discussion featuring thought leaders from technology and digital culture. This expert panel addressed how to navigate the...

Continue Reading
Empowering First-Time Homebuyers: New American Funding's Bold Launch

Updated Category News Views 237

New Campaign Inspires First-Time Homebuyers New American Funding (NAF), a prominent independent mortgage lender, is breaking new ground with its latest campaign aimed at revitalizing the home-buying experience for the next generation. The initiative, dubbed "Hell Yeah You're Buying a Home," is designed to ignite enthusiasm and confidence in first-time homebuyers,...

Continue Reading
Projected Growth of Monk Fruit Sweeteners Market Through 2032

Updated Category News Views 153

Monk Fruit Sweeteners Market Growth Overview The monk fruit sweeteners market is witnessing a significant transformation, spurred by health-conscious consumers seeking natural alternatives to sugar. This market is projected to experience a steady growth trajectory, reaching a remarkable $147.2 million by 2032. The expected compound annual growth rate (CAGR) is estimated...

Continue Reading
Celldex Therapeutics Secures Buy Ratings Amid Positive Data

Updated Category News Views 104

Celldex Therapeutics (NASDAQ: CLDX) found itself in the spotlight back in 2024 when TD Cowen maintained a Buy rating on its shares following a detailed review of long-term data concerning barzolvolimab, a treatment for Chronic Spontaneous Urticaria (CSU). The standout here? The drug showcased a jaw-dropping complete response (CR) rate hitting 71% at the 52-week mark. Now...

Continue Reading